Applications open for NERVE Program – Canada

Funding Information

• The program awards $100,000 in non-dilutive funding, access to training opportunities and workshops, and mentorship to support entrepreneurs in building and growing their neurotech company.
• The $100,000 cash award should be used for project-related costs and may be partially used as a stipend. The allocation of funds is subject to approval by OBI and should align with the project plan.
• Successful applicants will develop milestones for the commercialization of the neurotechnology and will sign a milestone-based agreement with OBI.
• The funding to the entrepreneur during the one-year program will be released in 3 tranches and the release of funds is contingent on achieving milestones outlined in the milestone-based agreement between the entrepreneur and OBI.
• Each awardee will be assigned an industry-based mentor(s) and liaise with OBI through a dedicated point of contact.
• It is mandatory for all awardees to attend training and support programs hosted by OBI while enrolled in the program.
• Awardees will also be invited to selective programs and events run by OBI’s partners.

Program Eligibility

• The program is aimed at supporting 5 early-stage entrepreneurs based in Canada.
• Preference is given to applicants who have completed a post-graduate fellowship within the past 5 years.
• The applicant must commit to being a full-time entrepreneur during the duration of the program.
• The applicant must have an incorporated company or have plans to incorporate a neurotech company based in Canada.
• The company is focused on developing and commercializing a technology based on scientific research that has a fundamental impact on how people understand, diagnose, improve or treat brain and brain-related disorders (neurological, neuropsychiatric, and/or sensory diseases). Note: programs or services are not eligible.
• The awarded funds must be used to commercialize a neurotechnology (e.g. devices, therapeutics, software/ICT). The use of funds will be reviewed and approved by OBI.

For more information, visit Ontario Brain Institute.